Navigation Links
Microfluidic Systems (MFSI) is Awarded Four New Patents in the Field of Automated Biological Sample Processing and Detection.
Date:9/23/2010

FREMONT, Calif., Sept. 23 /PRNewswire/ -- Microfluidic Systems, a privately-held company, announced today that they received four new patents in the area of automated biological sample processing and detection. These patents include: number 7,785,868, entitled "Apparatus to Automatically Lyse A Sample".  This patent covers a broad set of claims describing an instrument that controls critical conditions such as temperature, power, and time of ultrasonic energy-based sample lysis protocols. As well, MFSI was awarded patent number, 7,785,869, entitled "Sonication to Selectively Lyse Different Cell Types". This patent describes an apparatus to automate the differential extraction of specific cell types within a mixed sample. Thirdly, a patent was awarded entitled "Integrated Airborne Substance Collection and Detection System", number 7,633,606.  In addition a patent entitled "Automated Particle Collection Off of Fan Blades into a Liquid Buffer" has been allowed, and MFSI is awaiting assignment of that patent number.  These latter two patents are parts of a series of integrated systems developed to perform automated airborne pathogen collection, processing and detection – a key area of strength for MFSI.

"MFSI continues to build a strong intellectual property base in the area of biological sample collection, processing, and detection," Dr. M. Allen Northrup, MFSI President and CEO said. "We have built a repertoire of proprietary technology, expertise and capabilities as exemplified by these new patents," he added.

Microfluidic Systems (MFSI), www.microfluidicsystems.com, was founded in 2001 and is focused on the development of microfluidic systems for automated preparation of and performance of biological assays. MFSI personnel have been involved with the development of automated DNA-based pathogen detection systems and microfluidics for the US Government and commercial markets for over 25 years, including the world's first miniaturized, portable, battery-operated, real-time, polymerase-chain-reaction (PCR)-based detection system. For more information, please contact MFSI at 510-354-0400 or visit the website, www.microfluidicsystems.com. M. Allen Northrup Ph.D.CEO and Chief Technology OfficerMicroFluidic Systems47790 Westinghouse DrFremont, CA 94539510-354-0400 ext 201510-354-0404 (fax)northrup@microfluidicsystems.comwww.microfluidicsystems.com
'/>"/>

SOURCE Microfluidic Systems
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. LOREAL and Hurel Corporation Announce R&D Collaboration to Develop a Non-Animal Alternative, Microfluidic Biochip
2. Microfluidics Enters into Exclusive Partnership with ATS Scientific to Expand Distribution in Canada
3. Microfluidics International Corporation to Report Fourth Quarter and Year-end 2009 Financial Results on February 23, 2010
4. Microfluidics International Corporation Announces Fourth Quarter and Year-End 2009 Financial Results
5. Microfluidics Announces Two New Board Members
6. Biocept, Inc. Announces Issuance of Patent for its Microfluidic Technology
7. Microfluidics International Corporation to Report Second Quarter 2010 Financial Results on August 10, 2010
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Flexible Medical Systems Raises $1.2M Seed Investment for Initial Human Trials
10. Boston Scientific to Release Broad Range of Clinical Trial Data Reinforcing Safety and Efficacy of Taxus(R) Coronary Stent Systems at TCT 2007
11. BD and PEPFAR Collaborate to Strengthen Laboratory Systems in Fight Against HIV/AIDS and TB
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- Research and Markets has announced the addition of ... report to their offering. ... The report provides separate comprehensive analytics for the US, Canada ... Asia-Pacific , Latin America , and ... 2015 through 2022. Also, a six-year historic analysis is provided for these ...
(Date:3/24/2017)... surveys with 9,250 insured consumers fielded from February 2015 ... help from their plans in five key areas: 1) ... help closing gaps in care, 3) better digital connections, ... real-time guidance. Meeting these needs is essential to promoting ... A Reason to Stay Engaged in Health ...
(Date:3/24/2017)... GENEVA , March 24, 2017 ... revitalizes efforts to develop sutezolid as effective response to ... Day, TB Alliance and the Medicines Patent Pool (MPP) ... sutezolid, an antibiotic drug candidate which demonstrated encouraging results ... of sutezolid in combination with other TB drugs and ...
Breaking Medicine Technology:
(Date:3/24/2017)... (PRWEB) , ... March 24, 2017 , ... ... financial planning, and related services to families and business owners across eastern Michigan, ... at feeding regional families struggling with financial difficulties. , The Oxford/Orion FISH Food ...
(Date:3/24/2017)... PA (PRWEB) , ... March 24, 2017 , ... ... Oncology Nursing Society (ONS) wanted to create a communications platform that positions them ... this goal, Elliance and ONS reinvented their online publication as an always-on, always-fresh ...
(Date:3/24/2017)... ... March 24, 2017 , ... The law firm of Enea, ... pleased to announce Westchester resident Lauren C. Enea has joined the firm as an ... will concentrate her practice in elder law, Medicaid planning and applications, and Wills, Trusts ...
(Date:3/24/2017)... ... 2017 , ... Empower Brokerage, located in Southlake, Texas, intends ... , In February, 2017, Empower Brokerage introduced their new “Performance Partners” program to ... teach how to maximize their sales efforts, as well as how to best ...
(Date:3/24/2017)... ... 24, 2017 , ... “End Time GPS”: a dauntless and enlightened study ... Time GPS” is the creation of published author, Wesley Gerboth, a World War II ... and space-vehicle projects. Now, at age ninety-one, he shares the Wisdom God bestowed upon ...
Breaking Medicine News(10 mins):